Raymond James & Associates Becton Dickinson & CO Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Becton Dickinson & CO stock. As of the latest transaction made, Raymond James & Associates holds 578,920 shares of BDX stock, worth $130 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
578,920
Previous 600,248
3.55%
Holding current value
$130 Million
Previous $140 Million
0.5%
% of portfolio
0.09%
Previous 0.09%
Shares
30 transactions
Others Institutions Holding BDX
# of Institutions
1,803Shares Held
260MCall Options Held
1.27MPut Options Held
1.09M-
Vanguard Group Inc Valley Forge, PA26.7MShares$5.99 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY22.3MShares$4.99 Billion0.12% of portfolio
-
State Street Corp Boston, MA14.1MShares$3.16 Billion0.13% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.3MShares$2.77 Billion0.32% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.1MShares$2.72 Billion1.7% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $63.9B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...